Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference28 articles.
1. A. Dasari, C. Shen, D. Halperin, B. Zhao, S. Zhou, Y. Xu, T. Shih, J.C. Yao, Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. AMA Oncol. 3, 1335–1342 (2017)
2. J.C. Yao, M. Hassan, A. Phan, C. Dagohoy, C. Leary, J.E. Mares, E.K. Abdalla, J.B. Fleming, J.N. Vauthey, A. Rashid, D.B. Evans, One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol. 26, 3063–3072 (2008)
3. S. Singh, J. Hallet, C. Rowsell, C.H. Law, Variability of Ki67 labeling index in multiple neuroendocrine tumors specimens over the course of the disease. Eur. J. Surg. Oncol. 40, 1517–1522 (2014)
4. S. Richards-Taylor, C. Tilley, E. Jaynes, H. Hu, T. Armstrong, N.W. Pearce, R. Plant, J. Cave, Clinically significant differences in Ki-67 proliferation index between primary and metastases in resected pancreatic neuroendocrine tumors. Pancreas 46, 1354–1358 (2016)
5. C. Shi, R.S. Gonzalez, Z. Zhao, T. Koyama, T.C. Cornish, K.R. Hande, R. Walker, M. Sandler, J. Berlin, E.H. Liu, Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors. Am. J. Clin. Pathol. 143, 398–404 (2015)
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献